Does LEVOTHYROXINE Cause Bladder transitional cell carcinoma? 24 Reports in FDA Database
Thyroid Balance & Feminine Wellness
Thyrafemme Balance — 14 gentle ingredients for energy, mood & hormonal harmony.
According to the FDA Adverse Event Reporting System (FAERS), 24 reports of Bladder transitional cell carcinoma have been filed in association with LEVOTHYROXINE (LEVOTHYROXINE SODIUM). This represents 0.0% of all adverse event reports for LEVOTHYROXINE.
24
Reports of Bladder transitional cell carcinoma with LEVOTHYROXINE
0.0%
of all LEVOTHYROXINE reports
0
Deaths
24
Hospitalizations
How Dangerous Is Bladder transitional cell carcinoma From LEVOTHYROXINE?
Of the 24 reports, 24 (100.0%) required hospitalization.
Is Bladder transitional cell carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LEVOTHYROXINE. However, 24 reports have been filed with the FAERS database.
What Other Side Effects Does LEVOTHYROXINE Cause?
Fatigue (10,494)
Headache (6,425)
Insomnia (4,663)
Drug ineffective (4,556)
Alopecia (4,491)
Weight increased (4,130)
Nausea (4,013)
Palpitations (3,825)
Dizziness (3,761)
Asthenia (3,694)
What Other Drugs Cause Bladder transitional cell carcinoma?
PIOGLITAZONE (398)
ADALIMUMAB (96)
METHOTREXATE (95)
RITUXIMAB (74)
TOCILIZUMAB (68)
INFLIXIMAB (63)
SULFASALAZINE (55)
HYDROXYCHLOROQUINE (50)
PREDNISONE (48)
LENALIDOMIDE (42)
Which LEVOTHYROXINE Alternatives Have Lower Bladder transitional cell carcinoma Risk?
LEVOTHYROXINE vs LEVOTHYROXINE\LEVOTHYROXINE
LEVOTHYROXINE vs LEVOTHYROXINE\LIOTHYRONINE
LEVOTHYROXINE vs LEVOXYL
LEVOTHYROXINE vs LEXAPRO
LEVOTHYROXINE vs LEXISCAN